Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1672-2025

Beckman Coulter Inc. recalls DxC 500 AU Clinical Chemistry Analyzer

Beckman Coulter Inc.Brea, CA, United StatesReported May 7, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

The reason for the recall is incorrect sample barcode identification and processing errors that result in the reporting of erroneous and delayed results.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 Software versions: V1.3, V1.4, V1.4.1, V1.4.2, V1.4.3 The Beckman Coulter DxC 500 AU Clinical Chemistry Analyzer is an automated chemistry analyzer that measures analytes in samples, in combination with appropriate reagents, calibrators, quality control (QC) material and other accessories. This system is for in vitro diagnostic use only
    UDI-DI codeCatalog # Number
    138 affected lots
    20240901702024060094202407011420240901742024070118C63520149876665450652023060005
    +130 more2023070009202307001020230900152023090016202310001920231000202023110022202401003320240100352024010036202401003720240100382024020041202402004220240200432024020045202402004620240200472024030049202403005120240300522024030053202404005620240400592024050064202405007020240500722024060075202406008820240600962024060101202406010320240601042024060106202407010920240701102024070111202407011620240701282024070129202407013020240701312024070132202408013820240801392024080142202408014520240801572024080159202409017720240901792024090183202409019020240901922024090194202409019520240901972024100205202410020720241002092024100212202410021520241002262024100228202410023020250102482023080012202311002320240100242024010025202401002720240100282024010029202401003020240100312024010032202401003420240300552024040060202404006220240400632024050066202405006820240500742024060077202406008220240600852024060099202406010220240601072024070108202407011320240701152024070119202407012020240701212024070123202407012420240701252024070126202407012720240701342024070136202408014120240801442024080146202408014820240801492024080150202408015220240801532024080155202408016120240901632024090165202409016720240901722024090176202409018120240901852024090188202409019920241002012024100214202410021720241002192024100222202410022420250102462025010250

What the firm is doing

On 03/17/2025, the firm sent an "URGENT MEDICAL DEVICE RECALL" Letter via email and postal mail to customers informing them that it was determined that the DxC 500 AU Clinical Chemistry Analyzer might assign a test result to an incorrect sample ID under the following workflow conditions. If after loading a barcoded sample tube (Sample A) analyzes are not completed or remain "in pending", and operator attempts to analyze a second sample tube (Sample B) in the same positions, the analyzer will complete and report the pending tests associated with Sample A. No results will be reported for Sample B. Customers are instructed to: . Beckman Coulter recommends reviewing your laboratory workflow, sample labeling/label integrity and positioning to determine impact and sharing this with your laboratory and/or Medical Director. . For current software version is V1.3, V1.4, V1.4.1, or V1.4.2 customers, contact your Beckman Coulter service representative at your earliest convenience to upgrade to software V1.4.3. To check the software version, follow the instructions in the Viewing Analyzer Version Information topic in the IFU. . The latest available system software (software V1.4.3) provides improved sample event information and real time reporting, identifying the specific location of the sample with tests that are not completed. This software will help in the management of this issue. . Follow the attached appendix A Job Aid, which will prevent the operator workflow described in the ISSUE section. The Job Aid will outline how to use the sample list to manage the samples which have not completed. . There is no requirement to reverify applications, for example, precision studies. . Beckman Coulter recommends posting this Recall Letter on or near the affected systems until the corrections have been made. any questions, contact Customer Support Center: . From website: http://www.beckmancoulter.com . Troubleshooting Hotline: (800) 854-3633

DistributionShow details

Worldwide - U.S. Nationwide distribution including in the states of AL, CA, CO, GA, ID, IL, IN, LA, MA, MI,MN, MS, MT, NC, NM, NV, NY, OK, OR, PA, PR, SC, TN, TX, WA, and WI. The countries of Australia, Belgium, Bosnia and Herzegovina, Canada, Chile, Croatia, Egypt, Ethiopia, France, Georgia, Germany, Ghana, India, Italy, Korea, Lebanon, Libya, Malaysia, Netherlands, North Macedonia, Oman, Paraguay, Philippines, Poland, Puerto Rico, Qatar, Saudi Arabia, Seychelles, Slovakia, South Africa, Spain, Switzerland, and Tunisia.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls